Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
更正：PD-1/PD-L1免疫检查点疗法在自身免疫性肝病和胆汁淤积性肝病患者中显示出良好的安全性。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1369747
Kocheise, Lorenz; Piseddu, Ignazio; Vonderlin, Joscha; Tjwa, Eric T; Buescher, Gustav; Meunier, Lucy; Goeggelmann, Pia; Fianchi, Francesca; Dumortier, Jérôme; Barciela, Mar Riveiro; Gevers, Tom J G; Beretta-Piccoli, Benedetta Terziroli; Londoño, Maria-Carlota; Frankova, Sona; Roesner, Thomas; Joerg, Vincent; Schmidt, Constantin; Glaser, Fabian; Sutter, Jan P; Fründt, Thorben W; Lohse, Ansgar W; Huber, Samuel; von Felden, Johann; Sebode, Marcial; Schulze, Kornelius
